Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 61083 | 122.42 |
09:34 ET | 16603 | 123.96 |
09:36 ET | 73341 | 125.735 |
09:38 ET | 38487 | 126.19 |
09:39 ET | 58363 | 127.02 |
09:41 ET | 46870 | 127.28 |
09:43 ET | 57912 | 128.05 |
09:45 ET | 38559 | 128.84 |
09:48 ET | 51708 | 129.005 |
09:50 ET | 47205 | 129.05 |
09:52 ET | 82737 | 128.44 |
09:54 ET | 43271 | 127.296 |
09:56 ET | 19728 | 126.94 |
09:57 ET | 68648 | 126.81 |
09:59 ET | 17191 | 126.5 |
10:01 ET | 16092 | 126.215 |
10:03 ET | 17191 | 126.126 |
10:06 ET | 14645 | 126.2524 |
10:08 ET | 14839 | 126.4372 |
10:10 ET | 60490 | 126.6 |
10:12 ET | 17658 | 127.32 |
10:14 ET | 20683 | 127.12 |
10:15 ET | 19024 | 126.9 |
10:17 ET | 13801 | 127.2725 |
10:19 ET | 13122 | 127.55 |
10:21 ET | 28769 | 126.625 |
10:24 ET | 27893 | 126.595 |
10:26 ET | 6239 | 126.54 |
10:28 ET | 11626 | 126.475 |
10:30 ET | 9472 | 126.5 |
10:32 ET | 30098 | 126.14 |
10:33 ET | 14639 | 126.255 |
10:35 ET | 15275 | 126.285 |
10:37 ET | 11643 | 126.495 |
10:39 ET | 14652 | 126.09 |
10:42 ET | 29637 | 124.99 |
10:44 ET | 38262 | 125.76 |
10:46 ET | 8369 | 125.54 |
10:48 ET | 12320 | 125.18 |
10:50 ET | 15879 | 124.62 |
10:51 ET | 9649 | 124.345 |
10:53 ET | 17037 | 123.855 |
10:55 ET | 7419 | 123.7 |
10:57 ET | 15080 | 123.16 |
11:00 ET | 24044 | 123.93 |
11:02 ET | 8328 | 124.2 |
11:04 ET | 8339 | 124.13 |
11:06 ET | 18395 | 124.255 |
11:08 ET | 20343 | 123.68 |
11:09 ET | 10422 | 123.45 |
11:11 ET | 8214 | 123.38 |
11:13 ET | 5732 | 123.22 |
11:15 ET | 13108 | 123.45 |
11:18 ET | 4897 | 123.17 |
11:20 ET | 26050 | 123.455 |
11:22 ET | 20514 | 123.88 |
11:24 ET | 20384 | 123.64 |
11:26 ET | 3755 | 124.25 |
11:27 ET | 8483 | 124.02 |
11:29 ET | 21717 | 124.21 |
11:31 ET | 5600 | 124.39 |
11:33 ET | 7195 | 124.5952 |
11:36 ET | 8216 | 124.02 |
11:38 ET | 5443 | 124.0601 |
11:40 ET | 8103 | 124.26 |
11:42 ET | 5618 | 123.78 |
11:44 ET | 3946 | 124.18 |
11:45 ET | 3450 | 124.0834 |
11:47 ET | 4731 | 124.24 |
11:49 ET | 3194 | 123.99 |
11:51 ET | 13819 | 123.88 |
11:54 ET | 2996 | 123.96 |
11:56 ET | 3095 | 123.86 |
11:58 ET | 17679 | 123.9375 |
12:00 ET | 4985 | 123.82 |
12:02 ET | 6349 | 123.96 |
12:03 ET | 5938 | 123.92 |
12:05 ET | 13315 | 123.83 |
12:07 ET | 6398 | 123.63 |
12:09 ET | 4548 | 123.36 |
12:12 ET | 3401 | 123.2501 |
12:14 ET | 7366 | 123.23 |
12:16 ET | 3287 | 123.3 |
12:18 ET | 3413 | 123.28 |
12:20 ET | 5223 | 123.5734 |
12:21 ET | 1500 | 123.53 |
12:23 ET | 7869 | 123.57 |
12:25 ET | 3653 | 123.36 |
12:27 ET | 4750 | 123.29 |
12:30 ET | 5352 | 123.25 |
12:32 ET | 1332 | 123.235 |
12:34 ET | 6212 | 123.36 |
12:36 ET | 2312 | 123.315 |
12:38 ET | 4730 | 123.3 |
12:39 ET | 6906 | 123.534 |
12:41 ET | 850 | 123.5388 |
12:43 ET | 2062 | 123.546 |
12:45 ET | 1870 | 123.5 |
12:48 ET | 2200 | 123.405 |
12:50 ET | 1914 | 123.48 |
12:52 ET | 3249 | 123.38 |
12:54 ET | 5775 | 123.1101 |
12:56 ET | 1400 | 123.32 |
12:57 ET | 1100 | 123.46 |
12:59 ET | 2114 | 123.305 |
01:01 ET | 3912 | 123.27 |
01:03 ET | 16492 | 123.085 |
01:06 ET | 3817 | 123 |
01:08 ET | 6414 | 123.0016 |
01:10 ET | 8687 | 122.77 |
01:12 ET | 5065 | 122.88 |
01:14 ET | 2520 | 122.88 |
01:15 ET | 1899 | 122.87 |
01:17 ET | 6590 | 122.9275 |
01:19 ET | 14969 | 123.105 |
01:21 ET | 1893 | 123.1542 |
01:24 ET | 2263 | 122.7601 |
01:26 ET | 3645 | 122.76 |
01:28 ET | 8116 | 122.425 |
01:30 ET | 4947 | 122.7699 |
01:32 ET | 2656 | 122.8666 |
01:33 ET | 5023 | 122.53 |
01:35 ET | 2986 | 122.64 |
01:37 ET | 2981 | 122.85 |
01:39 ET | 5740 | 122.83 |
01:42 ET | 4940 | 122.64 |
01:44 ET | 911 | 122.756 |
01:46 ET | 2989 | 122.53 |
01:48 ET | 7614 | 122.635 |
01:50 ET | 2854 | 122.5301 |
01:51 ET | 6912 | 122.3321 |
01:53 ET | 3976 | 122.29 |
01:55 ET | 8167 | 122.34 |
01:57 ET | 5244 | 122.36 |
02:00 ET | 32476 | 122.22 |
02:02 ET | 32495 | 122.35 |
02:04 ET | 6206 | 122.23 |
02:06 ET | 2600 | 122.2 |
02:08 ET | 3127 | 122.31 |
02:09 ET | 5005 | 122.27 |
02:11 ET | 3575 | 122.49 |
02:13 ET | 9630 | 122.11 |
02:15 ET | 2790 | 122.05 |
02:18 ET | 2150 | 122.07 |
02:20 ET | 5193 | 122.17 |
02:22 ET | 14343 | 122.165 |
02:24 ET | 19836 | 121.6401 |
02:26 ET | 22163 | 121.41 |
02:27 ET | 2442 | 121.44 |
02:29 ET | 8478 | 121.98 |
02:31 ET | 15762 | 121.65 |
02:33 ET | 5558 | 121.79 |
02:36 ET | 3625 | 121.84 |
02:38 ET | 6312 | 121.875 |
02:40 ET | 3709 | 121.7501 |
02:42 ET | 4165 | 121.81 |
02:44 ET | 4150 | 121.63 |
02:45 ET | 3688 | 121.62 |
02:47 ET | 4300 | 121.6175 |
02:49 ET | 4276 | 121.5672 |
02:51 ET | 19581 | 121.46 |
02:54 ET | 2510 | 121.53 |
02:56 ET | 8270 | 121.65 |
02:58 ET | 4210 | 121.6772 |
03:00 ET | 3684 | 121.84 |
03:02 ET | 2247 | 121.57 |
03:03 ET | 5750 | 121.54 |
03:05 ET | 3627 | 121.5907 |
03:07 ET | 3455 | 121.6499 |
03:09 ET | 4886 | 121.48 |
03:12 ET | 6020 | 121.47 |
03:14 ET | 2396 | 121.43 |
03:16 ET | 6266 | 121.465 |
03:18 ET | 14189 | 121.24 |
03:20 ET | 32087 | 121.26 |
03:21 ET | 7533 | 121.354 |
03:23 ET | 7445 | 121.78 |
03:25 ET | 12700 | 121.552 |
03:27 ET | 3810 | 121.71 |
03:30 ET | 8902 | 121.68 |
03:32 ET | 14185 | 121.43 |
03:34 ET | 8224 | 121.48 |
03:36 ET | 3548 | 121.58 |
03:38 ET | 5113 | 121.476 |
03:39 ET | 3478 | 121.45 |
03:41 ET | 9529 | 121.29 |
03:43 ET | 10583 | 121.32 |
03:45 ET | 8470 | 121.53 |
03:48 ET | 6948 | 121.52 |
03:50 ET | 14154 | 121.7087 |
03:52 ET | 17296 | 121.64 |
03:54 ET | 27752 | 121.84 |
03:56 ET | 40299 | 121.92 |
03:57 ET | 41161 | 121.63 |
03:59 ET | 105826 | 121.46 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 46.5B | -7.8x | --- |
ICON PLC | 27.8B | 40.8x | +4.68% |
Biogen Inc | 33.5B | 28.7x | -18.14% |
Biontech SE | 20.2B | 163.8x | --- |
Grifols SA | 6.8B | 26.9x | --- |
Alnylam Pharmaceuticals Inc | 33.0B | -96.1x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $46.5B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -7.8x |
Price/Sales (TTM) | 9.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.